|

Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening

RECRUITINGSponsored by Hôpital Edouard Herriot
Actively Recruiting
SponsorHôpital Edouard Herriot
Started2017-11-03
Est. completion2021-11-01
Eligibility
Age45 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02738359

Summary

Efficacy of colonoscopy, colon capsule and fecal immunological test for colorectal cancer screening, in first degree relatives of patients with colorectal neoplasia: a prospective randomized study.

Eligibility

Age: 45 Years+Healthy volunteers accepted
Inclusion criteria:

* History of colorectal cancers (any age) in first-degree relatives (parents, children, siblings including half-brothers and sisters)
* Age \> or = 45 years
* No previous colorectal cancer screening
* Informed patient
* Patient having signed the consent form
* Patient affiliated to a social security system or recipient of such system

Exclusion criteria:

* Any previous colorectal cancer screening:

  * History of blood tests in the stool (hemoccult, fecal immunological test, ...)
  * History of colonic capsule screening
  * History of colonoscopy
* Any known advanced neoplasia or colorectal cancer
* Known genetic predisposition to colorectal cancer (very high risk group)
* Adults protected by law (under guardianship or trusteeship)
* Other metastatic cancers
* Life-threatening diseases

Conditions3

CancerColon CancerRectum Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.